AIDS no longer considered a death sentence

Dr. Julio Montaner remembers when an AIDS diagnosis was pretty much a death sentence.

“Now, it is a chronic illness,” said the doctor who has been on the forefront of research into the disease.

“Twenty years ago, if we were talking to a woman, we would have told her that her survival was compromised and she can’t have a normal reproductive life because she could pass the disease on to her partner or her children,” Montaner said.

“All of that has changed. Now, they can pursue a normal reproductive life, taking the appropriate precautions – and that’s very good news.”

Montaner is the clinical director for the B.C. Centre for Excellence in HIV/AIDS, as well as chairman of AIDS research and head of the division of AIDS at the faculty of medicine at the University of British Columbia and past-president of the International AIDS Society.

He’s also a doctor who was researching the virus before anyone knew what it was.

Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below